Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can expire. If ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The update about the popular semaglutide injections from drug manufacturer Novo Nordisk follows just two months after the FDA said that shortages of tirzepatide injections Zepbound and Mounjaro ...
Compounders are on alert after ... s two flagship products removed from the shortage list, compounders are no longer legally permitted to make and distribute their own versions of semaglutide.
Hims & Hers faces new headwinds in its weight management segment with the Food and Drug Administration ending the shortage of ...
The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...
Compounding of another big-selling GLP-1 drug – Eli Lilly's tirzepatide – was blocked in December after ... the semaglutide supply chain, given that Novo Nordisk "stated two weeks ago that ...